Healthcare & Pharmaceuticals Industry Press Releases

Published on October 4, 2023 - 11:30 GMT

Theratechnologie reçoit la date cible d'approbation de janvier 2024 à la licence de produit biologique (sBLA) pour la formulation ...

Le présent communiqué de presse constitue un « communiqué désigné » aux fins du supplément de prospectus de la Société daté du 16 décembre 2021 à son prospectus préalable de base simplifié daté du 14 décembre 2021. MONTRÉAL, 04 oct. 2023 (GLOBE NEWSWIRE) …

Distribution channels: Healthcare & Pharmaceuticals Industry ...

Published on October 4, 2023 - 11:30 GMT

Scinai Immunotherapeutics to Showcase its end-to-end cGMP Biologics CDMO Services at CPHI Barcelona 2023

JERUSALEM, Oct. 04, 2023 (GLOBE NEWSWIRE) -- via IBN – Scinai Immunotherapeutics Ltd. (Nasdaq: SCNI) today announced that it will be showcasing its CDMO services at CPHI Barcelona, one of the international pharmaceutical industry’s premier trade shows, …

Distribution channels: Healthcare & Pharmaceuticals Industry, Media, Advertising & PR ...

Published on October 4, 2023 - 11:30 GMT

Kura Oncology Announces Three Presentations at AACR-NCI-EORTC International Conference on Molecular Targets and Cancer ...

– Presentations to highlight preclinical data supporting combination of KO-2806 with targeted therapies, including TKIs, KRASG12C inhibitors and KRASG12D inhibitors – SAN DIEGO, Oct. 04, 2023 (GLOBE NEWSWIRE) -- Kura Oncology, Inc. (Nasdaq: KURA), a …

Distribution channels: Culture, Society & Lifestyle, Healthcare & Pharmaceuticals Industry ...

Published on October 4, 2023 - 11:30 GMT

Beyond Cancer™ Selected to Present Proffered Posters Discussing Data from the UNO Therapy Program at the 2023 AACR-NCI-EORTC ...

GARDEN CITY, N.Y. and HAMILTON, Bermuda, Oct. 04, 2023 (GLOBE NEWSWIRE) -- Beyond Cancer, Ltd., an affiliate of Beyond Air, Inc. (NASDAQ: XAIR) that is developing ultra-high concentration nitric oxide (UNO) as an immunotherapeutic for solid tumors, today …

Distribution channels: Healthcare & Pharmaceuticals Industry, Science ...

Published on October 4, 2023 - 11:30 GMT

Avertix and BIOS Acquisition Corporation Mutually Agree to Terminate Proposed Business Combination

EATONTOWN, N.J. and NEW YORK, Oct. 04, 2023 (GLOBE NEWSWIRE) -- Avertix Medical, Inc. (“Avertix” or the “Company”), formerly known as Angel Medical Systems, Inc., a company focused on improving long-term management and outcomes of high-risk coronary …

Distribution channels:

Published on October 4, 2023 - 11:20 GMT

Oats Market is Projected to be Worth $9.94Bn, Globally, by 2028 - The Insight Partners

Pune, India, Oct. 04, 2023 (GLOBE NEWSWIRE) -- According to our latest study on “Oats Market Size Report, Forecast to 2028 – COVID-19 Impact and Global Analysis – by Process, Category, Nature, Form, Application, and Geography,” the oats market is expected …

Distribution channels: Business & Economy, Food & Beverage Industry ...

Published on October 3, 2023 - 23:18 GMT

Innorna Receives IND Clearance by FDA Enabling Phase I Initiation for Herpes Zoster mRNA Vaccine

Innorna focuses on developing best-in-class LNP delivery technology and advancing innovative RNA therapies to address unmet medical needs globally. UNITED STATES, October 3, 2023 /⁨EINPresswire.com⁩/ -- Innorna, a clinical-stage biotech company pioneering …

Distribution channels: Companies, Healthcare & Pharmaceuticals Industry ...

Published on October 4, 2023 - 11:05 GMT

ZyVersa Therapeutics Announces New Peer-Reviewed Publication Reinforcing the Rationale for Inhibiting ASC Specks with IC 100 to ...

The paper, published in Pharmaceuticals, demonstrates that pyrin inflammasome-mediated inflammation induced by traumatic brain injury (TBI) contributes to cardiovascular co-morbidities through systemic release of proinflammatory mediators that activate …

Distribution channels: Healthcare & Pharmaceuticals Industry, Science ...